Fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial - Sculpher, M J; Lozano-Ortega, G; Sambrook, J (Am Heart J, 2009)